Pasithea Therapeutics

KTTA

Market cap $19.4M

0.8400 USD

0.0000

At close Updated Feb 4, 4:00 PM EST

Pre-market

After hours

0.8300

-0.0100

1.19%

1 day

5 days

-1.7%

1 month

-24.32%

3 months

9.37%

6 months

18.31%

Year to date

-29.41%

1 year

-59.62%

5 years

-98.82%

10 years

-98.82%

About: Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Employees: 4

Healthcare Biotechnology